AKTX

Akari Therapeutics
AKTX

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $892K invested in Akari Therapeutics in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

25% less capital invested

Capital invested by funds: $1.19M → $892K (-$298K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$89K
2
+$50
3
+$22

Top Sellers

1
-$89.3K
2
-$43.9K
3
-$22.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$512K
2
$273K
3
$73.8K
4
$32K
5
$468
6
$156
7
$50
8
$22
9
$16
10
–